Public preview. Funding rounds, founders, and growth signals require a free account.
Unlock full profile
Valink Therapeutics
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Series AHealthcareCambridge, MA11-50 employees
Last round
Seed
Stage
Series A
Status
Active
Founders & team
Growth signals
Track Valink Therapeutics on FlareSight
Get notified the moment Valink Therapeutics files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.